TCD's model is to out-license its products following successful completion of Phase II of the Regulatory process. However, we will evaluate and consider every offer as it is presented.
To further discuss opportunities to license TCD's products please contact email@example.com.
All rights reserved. 2011 TCD Pharma                                                                                                                             Designed by Freeman y la luz